Skip to content

Treatment of Plantar Fasciitis With Injection af Platelet-rich Plasma Into the Origin of the Plantar Fascia

Treatment of Plantar Fasciitis With Injection af Platelet-rich Plasma Into the Origin of the Plantar Fascia - a Prospective, Randomized and Double Blinded Study.

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01509274
Enrollment
90
Registered
2012-01-12
Start date
2011-08-31
Completion date
Unknown
Last updated
2012-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Plantar Fasciitis

Keywords

Plantar fasciitis, Plasma, PRP, Heel pain

Brief summary

The purpose of our study is to determine whether one injection with plasma into the origin of the plantar fascia is an effective treatment of plantar fasciitis. 90 patients will be randomized into three groups. 30 patients will be treated with one plasma injection, 30 patients will be treated with one injection with saline and 30 patients will do physiotherapy and use heel cups. The two groups who receive injections will do the same physiotherapy and use heel cups, as the conservatively treated group. Both groups randomized to receive an injection will have a 10 ml blood sample taken from their cubital vein. The sample is centrifuged for 5 minutes at 5000 rpm. No additives are added. 3 ml of plasma i obtained, and the syringe i blinded. Is the patient randomized to receive an injection with saline, a similar syringe is blinded with 3 ml of saline. The injection into to the origin of the plantar fascia i done 10 minutes after the sample of blood is obtained. The content of the syringe i blinded to both the investigator and the patient. The injection i performed from the medial aspect of the heel under guidance of ultrasound. No local/systemic analgetic is used. The content of the syringe is spread using peppering technique into the origin of the plantar fascia. Patients will do questionnaires at inclusion and after 1, 2, 3, 6 and 12 months. The questionaires will be Foot Function Index and SF-36 as well as questions about their use of analgetics, use of heel cups and intensity of their physiotherapy

Interventions

BIOLOGICALPlasma

3 ml plasma injected once into the plantar fascia

BIOLOGICALSaline

3 ml of saline injected once into the plantar fascia

OTHERPhysiotherapy + heel cap

Physiotherapy three times a day for 8 weeks. Heel caps until symptoms are gone

Sponsors

Kolding Sygehus
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* between 18 and 70 of age * Sore at the insertion of the plantar fascia on calcaneus * A VAS score of at least 4 at the insertion of the plantar fascia on calcaneus taking the first step in the morning * Symptoms for 6 to 12 months * Ability to understand danish and give informed consent

Exclusion criteria

* Previously operated in the same ankle or foot * Pain anywhere else in the foot on palpation otherwise than at the insertion of the plantar fascia on calcaneus * Inflammatory disease * Diabetes * Formerly rupture of the Achilles tendon * Formerly treated with plasma injections * Ongoing infection treated with antibiotics * Treated with steroid during the trial * Treatment of the plantar fasciitis exceeding conservative treatment * Use of crutches, walker or similar * Pregnancy

Design outcomes

Primary

MeasureTime frame
Pain on a VAS score

Secondary

MeasureTime frame
Disability

Countries

Denmark

Contacts

Primary ContactBjørn Nedergaard, Cand. Med.
bspn77@gmail.com0045 20204541

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026